Medical Director, Helen & Jacob Shaham Cancer & Blood Disorders Institute

Job Description - Medical Director, Helen & Jacob Shaham Cancer & Blood Disorders Institute (301939)

Job Description

Medical Director, Helen & Jacob Shaham Cancer & Blood Disorders Institute - 301939

Description

The Medical Director will provide strategic and clinical leadership for one of South Florida's premier pediatric hematology/oncology programs, guiding clinical operations, research direction, academic growth, and program development for children with cancer and blood disorders. Responsible for building on a strong foundation of philanthropic investment, academic affiliation, and state-funded research to advance world-class, family-centered pediatric cancer care and expand the frontiers of precision medicine and clinical research.

The Medical Director leads the Institute's clinical mission, strategic growth, academic advancement, research portfolio, and external engagement. Responsible for oversight of clinical services, multidisciplinary care models, faculty development, philanthropic relationships, and compliance with institutional and state-funded research requirements.

• Provide medical direction and oversight for all clinical services within the Institute, including hematology, oncology, stem cell and bone marrow transplant, sickle cell disease, and related subspecialty programs.
• Ensure delivery of high-quality, evidence-based, family-centered care consistent with national standards, including Children’s Oncology Group guidelines.
• Oversee day-to-day clinical operations, including inpatient and outpatient coordination, infusion and treatment scheduling, and multidisciplinary tumor board leadership.
• Lead quality improvement, patient safety, and clinical outcomes initiatives, including tracking and reporting of key clinical metrics.
• Maintain oversight of the Institute’s cancer registry program and ensure compliance with state and national reporting standards.
• Serve as a clinical resource and mentor to attending physicians, fellows, advanced practice providers, and nursing staff.
• Direct physician coverage models, on-call schedules, and escalation protocols to ensure consistent, high-quality coverage across all sites of care.
• Oversee credentialing, privileging, and ongoing performance evaluation of Institute medical staff in coordination with the Medical Executive Committee.
• Ensure integration of palliative care, psychosocial support, survivorship care, and other supportive services into the care model.
• Lead response planning for complex or high-acuity cases requiring coordination across multiple subspecialties.
• Partner with hospital administration to define and execute the Institute’s strategic growth plan, including service line expansion and new program development.
• Identify opportunities to grow clinical trial capacity, subspecialty services, and multidisciplinary care models.
• Represent the Institute in system-level planning related to Nicklaus Children’s Health System’s centers of excellence.
• Lead workforce planning and recruitment strategy to build subspecialty depth in areas such as neuro-oncology, cellular therapy, and survivorship.
• Develop and monitor annual operating and capital plans for the Institute in partnership with hospital finance and administrative leadership.
• Evaluate and implement new technologies, treatment modalities, and care delivery models that strengthen the Institute’s competitive position regionally and nationally.
• Support efforts to maintain and expand national rankings and recognitions, including U.S. News & World Report standing and Children’s Oncology Group membership status.
• Monitor the pediatric cancer landscape in Florida and the Southeast to identify strategic opportunities and competitive gaps.
• Provide oversight and direction for the Institute’s research portfolio, including grant-funded initiatives supported by the State of Florida and other funding sources.
• Direct the strategic deployment of the Institute’s Cancer Connect Collaborative Research Incubator Fund appropriation to expand clinical trials, advance innovative treatments, and strengthen research infrastructure.
• Oversee reporting and accountability requirements associated with…